vs
Side-by-side financial comparison of ACNB CORP (ACNB) and 4D Molecular Therapeutics, Inc. (FDMT). Click either name above to swap in a different company.
4D Molecular Therapeutics, Inc. is the larger business by last-quarter revenue ($85.1M vs $47.2M, roughly 1.8× ACNB CORP). ACNB CORP runs the higher net margin — 22.9% vs 22.8%, a 0.1% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 42.2%). ACNB CORP produced more free cash flow last quarter ($52.6M vs $28.5M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 22.1%).
ACNB Corp is a US-based financial holding company headquartered in Pennsylvania. It provides a full suite of financial solutions including retail and commercial banking, wealth management, trust services, and property & casualty insurance products. Its core market covers local communities, individual consumers, and small-to-medium enterprises across south-central Pennsylvania and northern Maryland.
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
ACNB vs FDMT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $47.2M | $85.1M |
| Net Profit | $10.8M | $19.4M |
| Gross Margin | — | — |
| Operating Margin | 27.9% | 17.3% |
| Net Margin | 22.9% | 22.8% |
| Revenue YoY | 42.2% | 8508900.0% |
| Net Profit YoY | 63.8% | 139.1% |
| EPS (diluted) | $1.10 | $0.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $47.2M | $85.1M | ||
| Q3 25 | $50.9M | $90.0K | ||
| Q2 25 | $50.3M | $15.0K | ||
| Q1 25 | $43.5M | $14.0K | ||
| Q4 24 | $33.2M | $1.0K | ||
| Q3 24 | $34.1M | $3.0K | ||
| Q2 24 | $33.3M | $5.0K | ||
| Q1 24 | $31.6M | $28.0K |
| Q4 25 | $10.8M | $19.4M | ||
| Q3 25 | $14.9M | $-56.9M | ||
| Q2 25 | $11.6M | $-54.7M | ||
| Q1 25 | $-272.0K | $-48.0M | ||
| Q4 24 | $6.6M | — | ||
| Q3 24 | $7.2M | $-43.8M | ||
| Q2 24 | $11.3M | $-35.0M | ||
| Q1 24 | $6.8M | $-32.4M |
| Q4 25 | 27.9% | 17.3% | ||
| Q3 25 | 37.2% | -67983.3% | ||
| Q2 25 | 29.7% | -396373.3% | ||
| Q1 25 | -1.3% | -383007.1% | ||
| Q4 24 | 24.8% | — | ||
| Q3 24 | 27.6% | -1704400.0% | ||
| Q2 24 | 42.8% | -849120.0% | ||
| Q1 24 | 26.9% | -136200.0% |
| Q4 25 | 22.9% | 22.8% | ||
| Q3 25 | 29.2% | -63195.6% | ||
| Q2 25 | 23.2% | -364386.7% | ||
| Q1 25 | -0.6% | -342657.1% | ||
| Q4 24 | 19.9% | — | ||
| Q3 24 | 21.1% | -1461433.3% | ||
| Q2 24 | 33.9% | -699060.0% | ||
| Q1 24 | 21.4% | -115717.9% |
| Q4 25 | $1.10 | $0.43 | ||
| Q3 25 | $1.42 | $-1.01 | ||
| Q2 25 | $1.11 | $-0.98 | ||
| Q1 25 | $-0.03 | $-0.86 | ||
| Q4 24 | $0.77 | — | ||
| Q3 24 | $0.84 | $-0.79 | ||
| Q2 24 | $1.32 | $-0.63 | ||
| Q1 24 | $0.80 | $-0.66 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $65.6M | $402.7M |
| Total DebtLower is stronger | $255.4M | — |
| Stockholders' EquityBook value | $420.0M | $505.7M |
| Total Assets | $3.2B | $566.7M |
| Debt / EquityLower = less leverage | 0.61× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $65.6M | $402.7M | ||
| Q3 25 | $102.1M | $305.1M | ||
| Q2 25 | $103.1M | $293.2M | ||
| Q1 25 | $123.6M | $321.4M | ||
| Q4 24 | $47.3M | $424.9M | ||
| Q3 24 | $58.1M | $501.9M | ||
| Q2 24 | $86.3M | $541.9M | ||
| Q1 24 | $53.1M | $525.9M |
| Q4 25 | $255.4M | — | ||
| Q3 25 | $255.4M | — | ||
| Q2 25 | $255.4M | — | ||
| Q1 25 | $255.3M | — | ||
| Q4 24 | $255.3M | — | ||
| Q3 24 | $255.3M | — | ||
| Q2 24 | $255.3M | — | ||
| Q1 24 | $255.3M | — |
| Q4 25 | $420.0M | $505.7M | ||
| Q3 25 | $408.6M | $369.0M | ||
| Q2 25 | $395.2M | $420.9M | ||
| Q1 25 | $386.9M | $469.7M | ||
| Q4 24 | $303.3M | $510.6M | ||
| Q3 24 | $306.8M | $552.9M | ||
| Q2 24 | $289.3M | $588.3M | ||
| Q1 24 | $279.9M | $600.6M |
| Q4 25 | $3.2B | $566.7M | ||
| Q3 25 | $3.3B | $424.0M | ||
| Q2 25 | $3.3B | $473.6M | ||
| Q1 25 | $3.3B | $515.7M | ||
| Q4 24 | $2.4B | $560.4M | ||
| Q3 24 | $2.4B | $604.0M | ||
| Q2 24 | $2.5B | $620.1M | ||
| Q1 24 | $2.4B | $629.9M |
| Q4 25 | 0.61× | — | ||
| Q3 25 | 0.62× | — | ||
| Q2 25 | 0.65× | — | ||
| Q1 25 | 0.66× | — | ||
| Q4 24 | 0.84× | — | ||
| Q3 24 | 0.83× | — | ||
| Q2 24 | 0.88× | — | ||
| Q1 24 | 0.91× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $53.6M | $28.6M |
| Free Cash FlowOCF − Capex | $52.6M | $28.5M |
| FCF MarginFCF / Revenue | 111.4% | 33.5% |
| Capex IntensityCapex / Revenue | 2.3% | 0.1% |
| Cash ConversionOCF / Net Profit | 4.96× | 1.47× |
| TTM Free Cash FlowTrailing 4 quarters | $92.2M | $-109.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $53.6M | $28.6M | ||
| Q3 25 | $23.2M | $-46.5M | ||
| Q2 25 | $17.8M | $-43.4M | ||
| Q1 25 | $-71.0K | $-47.8M | ||
| Q4 24 | $39.8M | $-134.6M | ||
| Q3 24 | $13.6M | $-29.4M | ||
| Q2 24 | $9.7M | $-30.2M | ||
| Q1 24 | $10.8M | $-29.1M |
| Q4 25 | $52.6M | $28.5M | ||
| Q3 25 | $22.8M | $-46.6M | ||
| Q2 25 | $17.6M | $-43.4M | ||
| Q1 25 | $-730.0K | $-48.4M | ||
| Q4 24 | $38.8M | $-138.4M | ||
| Q3 24 | $13.3M | $-31.2M | ||
| Q2 24 | $9.4M | $-30.6M | ||
| Q1 24 | $10.7M | $-29.8M |
| Q4 25 | 111.4% | 33.5% | ||
| Q3 25 | 44.7% | -51765.6% | ||
| Q2 25 | 35.0% | -289620.0% | ||
| Q1 25 | -1.7% | -345635.7% | ||
| Q4 24 | 117.0% | -13837100.0% | ||
| Q3 24 | 39.1% | -1038966.7% | ||
| Q2 24 | 28.3% | -611840.0% | ||
| Q1 24 | 33.9% | -106421.4% |
| Q4 25 | 2.3% | 0.1% | ||
| Q3 25 | 0.8% | 101.1% | ||
| Q2 25 | 0.4% | 440.0% | ||
| Q1 25 | 1.5% | 4507.1% | ||
| Q4 24 | 2.9% | 378600.0% | ||
| Q3 24 | 0.7% | 59266.7% | ||
| Q2 24 | 0.9% | 6980.0% | ||
| Q1 24 | 0.2% | 2535.7% |
| Q4 25 | 4.96× | 1.47× | ||
| Q3 25 | 1.56× | — | ||
| Q2 25 | 1.52× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 6.03× | — | ||
| Q3 24 | 1.88× | — | ||
| Q2 24 | 0.86× | — | ||
| Q1 24 | 1.60× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
